Effect of di(2-ethylhexyl) phthalate on Nrf2-regulated glutathione homeostasis in mouse kidney.


Journal

Cell stress & chaperones
ISSN: 1466-1268
Titre abrégé: Cell Stress Chaperones
Pays: Netherlands
ID NLM: 9610925

Informations de publication

Date de publication:
11 2020
Historique:
received: 05 03 2020
accepted: 25 05 2020
revised: 21 05 2020
pubmed: 6 6 2020
medline: 22 9 2021
entrez: 6 6 2020
Statut: ppublish

Résumé

Environmental toxicants such as phthalate have been involved in multiple health disorders including renal diseases. Oxidative damage is implicated in many alterations caused by phthalate especially the di(2-ethylhexyl) phthalate (DEHP), which is the most useful phthalate. However, information regarding its mechanism of renal damage is lacking. The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) regulates gene expression implicated in free radical scavenging and cytoprotection including the antioxidant glutathione (GSH) pathway. The aim of this study was to assess whether DEHP affects the Nrf2 pathway and the GSH concentration. Mice were divided into four groups: a control group and three groups treated with DEHP at different concentrations (5, 50, and 200 mg/kg body weight) for 30 days. Our results showed that DEHP altered the normal levels of serum biochemical parameters creatinine (CREA), urea, and lactate dehydrogenase (LDH). This phthalate caused oxidative damage through the induction of lipid peroxidation and protein oxidation as marked by increase of protein carbonyl (PC) and loss of protein-bound sulfhydryls (PSH). Simultaneously, DEHP treatment decreased the protein level of Nrf-2, HO-1, and GCLC (responsible of GSH synthesis) and decreased the GSH level. Inhibition of the Nrf2 pathway is related to the activation of the mitochondrial pathway of apoptosis. This apoptotic process is evidenced by an upregulation of p53 and Bax protein levels in addition to a downregulation of Bcl-2. Collectively, our data demonstrated that depletion of Nrf2 and GSH was associated with the elevation of oxidative stress and the activation of intrinsic apoptosis in mouse kidney treated with DEHP.

Identifiants

pubmed: 32500380
doi: 10.1007/s12192-020-01127-8
pii: 10.1007/s12192-020-01127-8
pmc: PMC7591664
doi:

Substances chimiques

Antioxidants 0
Biomarkers 0
NF-E2-Related Factor 2 0
Sulfhydryl Compounds 0
Malondialdehyde 4Y8F71G49Q
Diethylhexyl Phthalate C42K0PH13C
Heme Oxygenase-1 EC 1.14.14.18
Glutamate-Cysteine Ligase EC 6.3.2.2
Glutathione GAN16C9B8O

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

919-928

Références

Meat Sci. 2004 Feb;66(2):467-73
pubmed: 22064150
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Toxicol Appl Pharmacol. 1978 Jul;45(1):1-27
pubmed: 358497
Crit Rev Toxicol. 2006 May;36(5):459-79
pubmed: 16954067
J Biomed Biotechnol. 2012;2012:170325
pubmed: 22911014
Toxicol Sci. 2008 Sep;105(1):153-65
pubmed: 18411233
Basic Clin Pharmacol Toxicol. 2007 Feb;100(2):121-6
pubmed: 17244261
Free Radic Biol Med. 2009 Feb 15;46(4):443-53
pubmed: 19028565
Indian J Clin Biochem. 2010 Jan;25(1):86-91
pubmed: 23105891
World Allergy Organ J. 2012 Jan;5(1):9-19
pubmed: 23268465
Eur J Nutr. 2012 Oct;51(7):881-92
pubmed: 22042007
Toxicol Mech Methods. 2017 Sep;27(7):551-559
pubmed: 28532275
Regul Toxicol Pharmacol. 1999 Jun;29(3):327-57
pubmed: 10388618
Int J Mol Sci. 2017 May 17;18(5):
pubmed: 28513573
J Toxicol Environ Health. 1988;23(4):433-44
pubmed: 3361614
Neuroscience. 2015 Jan 22;284:225-233
pubmed: 25305668
Biochem Biophys Res Commun. 2003 May 9;304(3):437-44
pubmed: 12729577
Ann N Y Acad Sci. 1998 Nov 20;854:448-62
pubmed: 9928452
Drug Metab Rev. 2011 May;43(2):92-137
pubmed: 21495793
Toxicol Appl Pharmacol. 2017 Feb 1;316:17-26
pubmed: 28025108
Arch Toxicol. 2011 Apr;85(4):241-72
pubmed: 21365312
Asian J Androl. 2007 Mar;9(2):199-205
pubmed: 16855774
J Occup Health. 2008;50(2):169-80
pubmed: 18403868
Antioxid Redox Signal. 2006 Mar-Apr;8(3-4):444-77
pubmed: 16677090
Environ Sci Pollut Res Int. 2018 Mar;25(7):6545-6557
pubmed: 29255980
Oxid Med Cell Longev. 2009 Jul-Aug;2(3):166-71
pubmed: 20592772
Diabetes. 2013 Dec;62(12):4088-97
pubmed: 23974919
Reprod Toxicol. 2002 Sep-Oct;16(5):529-653
pubmed: 12406494
Biochimie. 2019 Oct;165:100-107
pubmed: 31325480
Arch Biochem Biophys. 1996 Sep 1;333(1):189-97
pubmed: 8806770
Diabetes. 2019 Jan;68(1):141-155
pubmed: 30352880
Cytotechnology. 2018 Feb;70(1):119-128
pubmed: 28689280
J Nutr. 2004 Mar;134(3):489-92
pubmed: 14988435
Biochem J. 2002 Aug 1;365(Pt 3):849-56
pubmed: 11982482
J Biol Chem. 1999 Feb 19;274(8):5088-96
pubmed: 9988757
Toxicol Appl Pharmacol. 2012 Jun 1;261(2):181-8
pubmed: 22521609
Int J Pharm. 1999 Mar 25;180(1):113-21
pubmed: 10089298
Chem Biol Interact. 2017 Mar 1;265:8-15
pubmed: 28115068
J Toxicol Environ Health B Crit Rev. 2009 Feb;12(2):157-74
pubmed: 19235623
Methods Enzymol. 1994;233:357-63
pubmed: 8015470
Clin Chem Lab Med. 2001 Jun;39(6):468-74
pubmed: 11506454
Anal Biochem. 1979 Jun;95(2):351-8
pubmed: 36810
Sci Total Environ. 2017 Feb 1;578:440-451
pubmed: 27836348
Stem Cell Res Ther. 2015 Dec 15;6:249
pubmed: 26670567
Sci Total Environ. 2018 Nov 1;640-641:1121-1131
pubmed: 30021277
Nat Protoc. 2006;1(6):3159-65
pubmed: 17406579
Clin Chim Acta. 2005 Nov;361(1-2):20-9
pubmed: 16004980
Biochem J. 2009 Dec 10;424(3):491-500
pubmed: 19778293
Anal Biochem. 1968 Oct 24;25(1):192-205
pubmed: 4973948
Toxicol Appl Pharmacol. 2010 Oct 1;248(1):52-62
pubmed: 20659492
Clin Chim Acta. 2003 Mar;329(1-2):23-38
pubmed: 12589963
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2016 May 20;34(5):346-51
pubmed: 27514415
Mutat Res. 2010 Aug 7;690(1-2):12-23
pubmed: 19799917
J Endocrinol. 2006 Sep;190(3):897-902
pubmed: 17003290
Biochem Pharmacol. 2013 Mar 15;85(6):705-17
pubmed: 23219527
Ann N Y Acad Sci. 2010 Jul;1201:96-103
pubmed: 20649545
J Cell Mol Med. 2015 Mar;19(3):581-94
pubmed: 25418486
Toxicology. 1975 May;4(2):253-64
pubmed: 1154425
Food Chem Toxicol. 2011 Jul;49(7):1565-71
pubmed: 21515331
J Neurochem. 1980 Oct;35(4):1013-4
pubmed: 7452288
Toxicol Lett. 2005 Jan 15;155(1):27-34
pubmed: 15585356
FEBS Lett. 2011 Mar 23;585(6):921-6
pubmed: 21354418
Environ Toxicol Pharmacol. 2015 May;39(3):1099-106
pubmed: 25899473
Am J Pathol. 2017 Dec;187(12):2858-2875
pubmed: 28935570
Biomolecules. 2020 Feb 17;10(2):
pubmed: 32079324

Auteurs

Ines Amara (I)

Faculty of Dental Medicine, Laboratory for Research on Biologically Compatible Compounds, University of Monastir, LR01SE1, Rue Avicenne, 5000, Monastir, Tunisia.
Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Catania, Italy.

Amal Salah (A)

Faculty of Dental Medicine, Laboratory for Research on Biologically Compatible Compounds, University of Monastir, LR01SE1, Rue Avicenne, 5000, Monastir, Tunisia.

Rim Timoumi (R)

Faculty of Dental Medicine, Laboratory for Research on Biologically Compatible Compounds, University of Monastir, LR01SE1, Rue Avicenne, 5000, Monastir, Tunisia.

Emna Annabi (E)

Faculty of Dental Medicine, Laboratory for Research on Biologically Compatible Compounds, University of Monastir, LR01SE1, Rue Avicenne, 5000, Monastir, Tunisia.

Maria Scuto (M)

Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Catania, Italy.

Angela Trovato (A)

Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Catania, Italy.

Fadwa Neffati (F)

Monastir University Hospital, Laboratory of Biochemistry-Toxicology, University of Monastir, Monastir, Tunisia.

Vittorio Calabrese (V)

Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Catania, Italy.

Salwa Abid-Essefi (S)

Faculty of Dental Medicine, Laboratory for Research on Biologically Compatible Compounds, University of Monastir, LR01SE1, Rue Avicenne, 5000, Monastir, Tunisia. salwaabid@yahoo.fr.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH